Integrated Bulk and Single Cell Transcriptomics Reveal That CD48 Marks an Immune Activated Microenvironment and Predicts Favorable Prognosis in Cervical Cancer
Abstract Cervical cancer is driven by persistent infection with high-risk human papillomavirus ( HPV ), and treatment options for recurrent or metastatic disease remain limited because immune checkpoint inhibitors benefit only a subset of patients. Reliable prognostic markers are therefore still needed. Here we integrated TCGA-CESC bulk transcriptomes with the GSE168652 single-cell dataset to screen immune-related cervical cancer targets (IRCTs) through weighted gene co-expression network analysis (WGCNA), machine-learning feature selection, and survival modeling, and then characterized the expression, prognostic value, and immune-microenvironment associations of the core gene. CD48 was selected as the consensus core gene by multiple algorithms, and its high expression was associated with longer overall survival (multivariate Cox HR = 0.498, 95% CI 0.302–0.822, p = 0.006). High CD48 coincided with elevated immune scores, increased infiltration of immune effector cells, and upregulation of several immune checkpoint molecules. Single-cell analysis showed that CD48 was expressed mainly in CD8 + T cells, natural killer (NK) cells, and monocytes/macrophages, whereas epithelial or tumor cells were nearly negative. Virtual knockout further showed that loss of CD48 significantly perturbed the cytotoxic effectors NKG7 and GZMA. These findings identify CD48 as a candidate marker that reflects an immune-activated microenvironment and carries independent prognostic value in cervical cancer.
Authors
- Hu Qinglan
- Yang Yang
- Jiajian Huang
- Xue Han
Publication Details
- Journal
- Research Square
- Published
- 2026-11-16
- DOI
- https://doi.org/10.21203/rs.3.rs-11239809/v1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- preprint